3 results on '"Lievens, Yolande"'
Search Results
2. Radiotherapy prioritization in 143 national cancer control plans: Correlation with radiotherapy machine availability, geography and income level.
- Author
-
Wilson, Brooke E., Oar, Andrew, Rodin, Danielle, Bray, Freddie, Ferlay, Jacques, Polo, Alfredo, Borras, Josep M., Bourque, Jean-Marc, Malik, Monica, Ynoe de Moraes, Fabio, Lievens, Yolande, Stevens, Lisa M., Zubizarreta, Eduardo, and Yap, Mei Ling
- Subjects
- *
LOW-income countries , *RADIOTHERAPY , *GLOBAL radiation , *GEOGRAPHY , *NATIONAL income - Abstract
• The inclusion rate of radiotherapy within 55% of NCCPs falls short of the 80% target set by GTFRCC. • Inclusion of radiotherapy specific planning in NCCPs varied according to income level and geography. • Prioritisation of radiotherapy in NCCPs is correlated with radiotherapy machine availability. • This study supports the importance of including radiotherapy in a country's NCCP. In 2015, the Global Task Force on Radiotherapy for Cancer Control (GTFRCC) called for 80% of National Cancer Control Plans (NCCP) to include radiotherapy by 2020. As part of the ongoing ESTRO Global Impact of Radiotherapy in Oncology (GIRO) project, we assessed whether inclusion of radiotherapy in NCCPs correlates with radiotherapy machine availability, national income, and geographic region. A previously validated checklist was used to determine whether radiotherapy was included in each country's NCCP. We applied the CCORE optimal radiotherapy utilisation model to the GLOBOCAN 2020 data to estimate the demand for radiotherapy and compared this to the International Atomic Energy Agency (IAEA) Directory of Radiotherapy Centres (DIRAC) supply data, stratifying by income level and world region. World regions were defined according to the IAEA. Complete data (including GLOBOCAN 2020, DIRAC and NCCP) was available for 143 countries. Over half (55%, n = 79) included a radiotherapy-specific checklist item within the plan. Countries which included radiotherapy services planning in their NCCP had a higher median number of machines (1.68 vs 0.75 machines/1000 patients needing radiotherapy, p < 0.001). There was significant regional and income-level heterogeneity in the inclusion of radiotherapy-related items in NCCPs. Low-income and Asia-Pacific countries were least likely to include radiation oncology services planning in their NCCP (p = 0.06 and p = 0.003, respectively). Few countries in the Asia-Pacific (18.6%) had a plan to develop or maintain radiation services, compared to 57% of countries in Europe. Only 55% of current NCCPs included any information regarding radiotherapy, below the GTFRCC's target of 80%. Prioritisation of radiotherapy in NCCPs was correlated with radiotherapy machine availability. There was regional and income-level heterogeneity regarding the inclusion of specific radiotherapy checklist items in the NCCPs. Ongoing efforts are needed to promote the inclusion of radiotherapy in future iterations of NCCPs in order to improve global access to radiation treatment. No direct funding was used in this research. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey.
- Author
-
Rodin, Danielle, Tawk, Bouchra, Mohamad, Osama, Grover, Surbhi, Moraes, Fabio Y., Yap, Mei Ling, Zubizarreta, Eduardo, and Lievens, Yolande
- Subjects
- *
HORMONE receptor positive breast cancer , *INTENSITY modulated radiotherapy , *DOSE fractionation , *WATERSHEDS , *METADATA , *BONE metastasis - Abstract
• Conventional and hypofractionated radiotherapy are equivalent in many disease sites. • Less hypofractionation in low- and lower-middle income countries and Asia-Pacific. • Lack of long-term data, inferior local control, and toxicity cited as barriers. • Significant global variation in use of hypofractionation for curative indications. • Accepted for palliation of breast, prostate, cervical cancer, and bone metastases. Multiple large trials have established the non-inferiority of hypofractionated radiotherapy compared to conventional fractionation. This study will determine real-world hypofractionation adoption across different geographic regions for breast, prostate, cervical cancer, and bone metastases, and identify barriers and facilitators to its use. An anonymous, electronic survey was distributed from January 2018 through January 2019 to radiation oncologists through the ESTRO-GIRO initiative. Predictors of hypofractionation were identified in univariable and multivariable regression analyses. 2316 radiation oncologists responded. Hypofractionation was preferred in node-negative breast cancer following lumpectomy (82·2% vs. 46·7% for node-positive; p < 0.001), and in low- and intermediate-risk prostate cancer (57·5% and 54·5%, respectively, versus 41·2% for high-risk (p < 0.001)). Hypofractionation was used in 32·3% of cervix cases in Africa, but <10% in other regions (p < 0.001). For palliative indications, hypofractionation was preferred by the majority of respondents. Lack of long-term data and concerns about local control and toxicity were the most commonly cited barriers. In adjusted analyses, hypofractionation was least common for curative indications amongst low- and lower-middle-income countries, Asia-Pacific, female respondents, small catchment areas, and in centres without access to intensity modulated radiotherapy. Significant variation was observed in hypofractionation across curative indications and between regions, with greater concordance in palliation. Using inadequate fractionation schedules may impede the delivery of affordable and accessible radiotherapy. Greater regionally-targeted and disease-specific education on evidence-based fractionation schedules is needed to improve utilization, along with best-case examples addressing practice barriers and supporting policy reform. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.